17.11.2013 Views

UNIVERSITÉ PARIS XI FACULTÉ DE MÉDECINE ... - Kb.u-psud.fr

UNIVERSITÉ PARIS XI FACULTÉ DE MÉDECINE ... - Kb.u-psud.fr

UNIVERSITÉ PARIS XI FACULTÉ DE MÉDECINE ... - Kb.u-psud.fr

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

SUMMARY<br />

Objectives : Characterize the target population of COPD case finding, in family<br />

medicine offices, by using the Piko6® spirometer, and evaluate the impact of<br />

this breathing test on patients’ management.<br />

Methods : Prospective study based on the outcomes of a questionnaire followed<br />

by a hand-held office spirometry measurements, offered to all smokers aged 18<br />

at least, having consulted family practitioners between 05/01/2007 and<br />

10/31/2007.<br />

Results : 109 patients included. The mean age was 39 years old. The prevalence<br />

of a possible airway obstruction, related to a FEV1/FEV6 ratio uncertain or<br />

pathological (less than 0,8), was 18% (19/109). Among these 19 subjects, 78,9%<br />

were men, all of them smoked for at least 10 years, and 79% of them smoked 10<br />

cigarets at least each day ; 47,4% were aged more than 50 years old, 31,6% were<br />

aged between 35 and 50, and 21,1% were aged 35 at least ; 94,7% had a specific<br />

management. The physicians concluded that this test improved patients’ care for<br />

36,7 % of the whole population tested . All the patients included were given a<br />

smoking cessation advice.<br />

Conclusion : The Piko6® is an acceptable and useful tool in general practices,<br />

for COPD case finding, particularly in smokers aged 35 at least, who smoke for<br />

at least 10 years.<br />

Keys Words : case finding ; chronic obstructive pulmonary disease ;<br />

FEV1/FEV6 ; Piko6® ; family medicine ; spirometry.<br />

- 83 -

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!